Prudential Financial’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.06M | Buy |
134,451
+8,035
| +6% | +$302K | 0.01% | 898 |
|
|
2025
Q1 | $4.77M | Sell |
126,416
-1,355
| -1% | -$51.2K | 0.01% | 858 |
|
|
2024
Q4 | $10.5M | Buy |
127,771
+31,118
| +32% | +$2.55M | 0.01% | 596 |
|
|
2024
Q3 | $11M | Buy |
96,653
+15,315
| +19% | +$1.75M | 0.02% | 646 |
|
|
2024
Q2 | $6.14M | Buy |
81,338
+26,497
| +48% | +$2M | 0.01% | 840 |
|
|
2024
Q1 | $3.75M | Buy |
54,841
+18,330
| +50% | +$1.25M | 0.01% | 1093 |
|
|
2023
Q4 | $2.29M | Buy |
36,511
+243
| +0.7% | +$15.3K | ﹤0.01% | 1351 |
|
|
2023
Q3 | $1.83M | Sell |
36,268
-84,332
| -70% | -$4.25M | ﹤0.01% | 1436 |
|
|
2023
Q2 | $6.02M | Buy |
120,600
+78,383
| +186% | +$3.91M | 0.01% | 810 |
|
|
2023
Q1 | $1.58M | Buy |
42,217
+853
| +2% | +$32K | ﹤0.01% | 1484 |
|
|
2022
Q4 | $1.98M | Buy |
41,364
+26,933
| +187% | +$1.29M | ﹤0.01% | 1311 |
|
|
2022
Q3 | $347K | Buy |
14,431
+265
| +2% | +$6.37K | ﹤0.01% | 2243 |
|
|
2022
Q2 | $308K | Buy |
+14,166
| New | +$308K | ﹤0.01% | 2333 |
|
|
2022
Q1 | – | Sell |
-9,920
| Closed | -$236K | – | 2669 |
|
|
2021
Q4 | $236K | Buy |
+9,920
| New | +$236K | ﹤0.01% | 2487 |
|